Xiaoping Ma

1.1k total citations
55 papers, 847 citations indexed

About

Xiaoping Ma is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Xiaoping Ma has authored 55 papers receiving a total of 847 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 13 papers in Pulmonary and Respiratory Medicine and 11 papers in Oncology. Recurrent topics in Xiaoping Ma's work include RNA modifications and cancer (6 papers), Cancer-related gene regulation (5 papers) and Lung Cancer Treatments and Mutations (5 papers). Xiaoping Ma is often cited by papers focused on RNA modifications and cancer (6 papers), Cancer-related gene regulation (5 papers) and Lung Cancer Treatments and Mutations (5 papers). Xiaoping Ma collaborates with scholars based in China, United States and Australia. Xiaoping Ma's co-authors include John F. Hancock, Dharini van der Hoeven, Kwang-Jin Cho, Robert G. Parton, Sravanthi Chigurupati, Yong Zhou, Yu Wu, John D. Ng, Wei Chen and Gregory D. Fairn and has published in prestigious journals such as Molecular and Cellular Biology, International Journal of Molecular Sciences and Medicine.

In The Last Decade

Xiaoping Ma

51 papers receiving 837 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoping Ma China 18 489 210 116 105 98 55 847
Jianshi Yu United States 20 668 1.4× 150 0.7× 39 0.3× 172 1.6× 56 0.6× 47 1.1k
Sanjiv Harpavat United States 17 620 1.3× 125 0.6× 86 0.7× 79 0.8× 54 0.6× 45 1.4k
Yvan Labrie Canada 22 615 1.3× 158 0.8× 154 1.3× 168 1.6× 55 0.6× 43 1.1k
Gina Fusaro United States 9 723 1.5× 121 0.6× 114 1.0× 200 1.9× 29 0.3× 12 920
Michel Janicot United States 15 439 0.9× 77 0.4× 70 0.6× 181 1.7× 56 0.6× 23 704
Shiying Miao China 19 731 1.5× 158 0.8× 136 1.2× 158 1.5× 114 1.2× 62 1.0k
Kazunari Hashiguchi Japan 15 711 1.5× 140 0.7× 40 0.3× 113 1.1× 26 0.3× 29 995
Stela S. Palii United States 13 636 1.3× 77 0.4× 123 1.1× 92 0.9× 32 0.3× 16 809
Pablo Gómez‐del Arco Spain 17 857 1.8× 174 0.8× 75 0.6× 168 1.6× 143 1.5× 24 1.3k
Elizabeth V. Nguyen United States 16 303 0.6× 115 0.5× 51 0.4× 109 1.0× 22 0.2× 27 635

Countries citing papers authored by Xiaoping Ma

Since Specialization
Citations

This map shows the geographic impact of Xiaoping Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoping Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoping Ma more than expected).

Fields of papers citing papers by Xiaoping Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoping Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoping Ma. The network helps show where Xiaoping Ma may publish in the future.

Co-authorship network of co-authors of Xiaoping Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoping Ma. A scholar is included among the top collaborators of Xiaoping Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoping Ma. Xiaoping Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yan, Lili, Lili Yi, Conghui Tian, et al.. (2025). TMEM176B inhibits ovarian cancer progression by regulating EMT via the Wnt/β-catenin signaling pathway. Journal of Translational Medicine. 23(1). 350–350.
2.
Wang, Yu, et al.. (2024). Case report: A novel FBXW7 gene variant causes global developmental delay. Frontiers in Genetics. 15. 1436462–1436462. 1 indexed citations
5.
Ma, Xiaoping, et al.. (2022). Pyrotinib-based treatments in HER2-positive breast cancer patients with brain metastases. Annals of Medicine. 54(1). 3084–3094. 9 indexed citations
6.
Wang, Pingyuan, Dharini van der Hoeven, Na Ye, et al.. (2021). Scaffold repurposing of fendiline: Identification of potent KRAS plasma membrane localization inhibitors. European Journal of Medicinal Chemistry. 217. 113381–113381. 8 indexed citations
7.
Chang, Junli, Hongfeng Ruan, Xiaobo Wang, et al.. (2021). Cantharidin inhibits osteosarcoma proliferation and metastasis by directly targeting miR-214-3p/DKK3 axis to inactivate β-catenin nuclear translocation and LEF1 translation. International Journal of Biological Sciences. 17(10). 2504–2522. 26 indexed citations
8.
Chang, Junli, et al.. (2021). Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models. Journal of Visualized Experiments. 4 indexed citations
9.
Wu, Yang, Jieli Wu, Jinghua Bu, et al.. (2020). High-fat diet induces dry eye-like ocular surface damages in murine. The Ocular Surface. 18(2). 267–276. 37 indexed citations
10.
Kattan, Walaa E., Wei Chen, Xiaoping Ma, et al.. (2019). Targeting plasma membrane phosphatidylserine content to inhibit oncogenic KRAS function. Life Science Alliance. 2(5). e201900431–e201900431. 30 indexed citations
11.
Li, Yong, Ping Gong, Wei Huang, et al.. (2018). miR-34a Regulates Multidrug Resistance via Positively Modulating OAZ2 Signaling in Colon Cancer Cells. Journal of Immunology Research. 2018. 1–13. 29 indexed citations
12.
Wang, Yuli, Wei Yuan, Xiaoping Ma, Xinyu Ma, & Ping Gong. (2018). Association between advanced NSCLC T790 M EGFR-TKI secondary resistance and prognosis. Medicine. 97(28). e11346–e11346. 11 indexed citations
13.
Ma, Xiaoping, et al.. (2018). Melatonin concentrations in serum of primary glaucoma patients. International Journal of Ophthalmology. 11(8). 1337–1341. 15 indexed citations
14.
Hoeven, Dharini van der, Kwang‐Jin Cho, Yong Zhou, et al.. (2017). Sphingomyelin Metabolism Is a Regulator of K-Ras Function. Molecular and Cellular Biology. 38(3). 39 indexed citations
15.
Ma, Xiaoping, et al.. (2015). Effect of Moisture Chamber Spectacles on Tear Functions in Dry Eye Disease. Optometry and Vision Science. 93(2). 158–164. 21 indexed citations
16.
Huang, Xiaobo, et al.. (2014). Research Progress in Applying Proteomics Technology to Explore Early Diagnosis Biomarkers of Breast Cancer, Lung Cancer and Ovarian Cancer. Asian Pacific Journal of Cancer Prevention. 15(20). 8529–8538. 26 indexed citations
17.
Ma, Xiaoping, et al.. (2014). Gene Expression Profiling of Human Kidneys Undergoing Laparoscopic Donor Nephrectomy. JSLS Journal of the Society of Laparoscopic & Robotic Surgeons. 18(1). 102–109. 3 indexed citations
18.
Ma, Xiaoping. (2012). The Study of Manufacturing Resource Database Based on Lean Shipbuilding.
19.
Li, Qiaoli, Minghao Yin, Xiaoping Ma, et al.. (2009). Apoptosis caused by Hsp90 inhibitor geldanamycin in Leishmania donovani during promastigote-to-amastigote transformation stage. Parasitology Research. 105(6). 1539–1548. 29 indexed citations
20.
Ma, Xiaoping. (2005). Shipbuilding Supply Chain Based on Green Manufacture. Ship Engineering. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026